Lipigon Pharmaceuticals AB (publ) LPGO.ST Stock
Lipigon Pharmaceuticals AB (publ) Price Chart
Lipigon Pharmaceuticals AB (publ) LPGO.ST Financial and Trading Overview
| Lipigon Pharmaceuticals AB (publ) stock price | 0.3 SEK |
| Previous Close | 0.35 SEK |
| Open | 0.38 SEK |
| Bid | 0.35 SEK x N/A |
| Ask | 0.37 SEK x N/A |
| Day's Range | 0.35 - 0.38 SEK |
| 52 Week Range | 0.3 - 3.25 SEK |
| Volume | 126 SEK |
| Avg. Volume | 108.25K SEK |
| Market Cap | 8.58M SEK |
| Beta (5Y Monthly) | 0.857547 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.09 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.3 SEK |
LPGO.ST Valuation Measures
| Enterprise Value | 2.81M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.079 |
Trading Information
Lipigon Pharmaceuticals AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.857547 |
| 52-Week Change | -86.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.25 SEK |
| 52 Week Low | 0.3 SEK |
| 50-Day Moving Average | 0.46 SEK |
| 200-Day Moving Average | 1 SEK |
LPGO.ST Share Statistics
| Avg. Volume (3 month) | 108.25K SEK |
| Avg. Daily Volume (10-Days) | 144.11K SEK |
| Shares Outstanding | 24.51M |
| Float | 18.9M |
| Short Ratio | N/A |
| % Held by Insiders | 6.30% |
| % Held by Institutions | 4.11% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -187.97% |
| Return on Equity (ttm) | -647.026% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.03 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -31655000 SEK |
| EBITDA | -35766752 SEK |
| Net Income Avi to Common (ttm) | -35525000 SEK |
| Diluted EPS (ttm) | -2.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.27M SEK |
| Total Cash Per Share (mrq) | 0.21 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.608 |
| Book Value Per Share (mrq) | -0.146 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31176000 SEK |
| Levered Free Cash Flow (ttm) | -17887376 SEK |
Profile of Lipigon Pharmaceuticals AB (publ)
| Country | Sweden |
| State | N/A |
| City | Umeå |
| Address | TvistevAegen 48 C |
| ZIP | 90736 |
| Phone | 46 7 05 78 17 68 |
| Website | https://www.lipigon.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia, cardiovascular disease, and other metabolic diseases. The company was incorporated in 2010 and is based in Umeå, Sweden.
Q&A For Lipigon Pharmaceuticals AB (publ) Stock
What is a current LPGO.ST stock price?
Lipigon Pharmaceuticals AB (publ) LPGO.ST stock price today per share is 0.3 SEK.
How to purchase Lipigon Pharmaceuticals AB (publ) stock?
You can buy LPGO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lipigon Pharmaceuticals AB (publ)?
The stock symbol or ticker of Lipigon Pharmaceuticals AB (publ) is LPGO.ST.
Which industry does the Lipigon Pharmaceuticals AB (publ) company belong to?
The Lipigon Pharmaceuticals AB (publ) industry is Biotechnology.
How many shares does Lipigon Pharmaceuticals AB (publ) have in circulation?
The max supply of Lipigon Pharmaceuticals AB (publ) shares is 126.42M.
What is Lipigon Pharmaceuticals AB (publ) Price to Earnings Ratio (PE Ratio)?
Lipigon Pharmaceuticals AB (publ) PE Ratio is 3.32777760 now.
What was Lipigon Pharmaceuticals AB (publ) earnings per share over the trailing 12 months (TTM)?
Lipigon Pharmaceuticals AB (publ) EPS is 0.09 SEK over the trailing 12 months.
Which sector does the Lipigon Pharmaceuticals AB (publ) company belong to?
The Lipigon Pharmaceuticals AB (publ) sector is Healthcare.
Lipigon Pharmaceuticals AB (publ) LPGO.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK GI FNSESEKGI | 2001.34 SEK 195.36 USD |
-1.07
|
— — | 1999.37 SEK 195.16 USD | 2020.41 SEK 197.22 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1616.97 EUR 1767.57 USD |
-1.5
|
— — | 1615.38 EUR 1765.82 USD | 1639.39 EUR 1792.08 USD | — - | — — |
| First North Health Care GI FN20GI | 939.04 EUR 1026.5 USD |
-1.95
|
— — | 937.79 EUR 1025.13 USD | 957.74 EUR 1046.94 USD | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 100.98 EUR 110.38 USD |
-1.33
|
— — | 100.89 EUR 110.29 USD | 102.35 EUR 111.88 USD | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1878.6 SEK 183.37 USD |
+0.16
|
— — | 1870.08 SEK 182.54 USD | 1889.76 SEK 184.46 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1513.01 EUR 1653.92 USD |
+0.67
|
— — | 1510.95 EUR 1651.67 USD | 1533.41 EUR 1676.23 USD | — - | — — |
| First North Health Care PI FN20PI | 934.74 EUR 1021.8 USD |
-1.95
|
— — | 933.5 EUR 1020.44 USD | 953.35 EUR 1042.15 USD | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 126.34 SEK 12.33 USD |
-0.9
|
— — | 126.23 SEK 12.32 USD | 127.53 SEK 12.45 USD | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 101.04 DKK 14.82 USD |
-1.33
|
— — | 100.96 DKK 14.8 USD | 102.42 DKK 15.02 USD | — - | — — |
- {{ link.label }} {{link}}